Form 10-Q PDL BIOPHARMA, INC. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
PDL BioPharma (PDLI) Misses Q3 EPS by 19c
November 5, 2015 8:30 AM ESTPDL BioPharma (NASDAQ: PDLI) reported Q3 EPS of $0.42, $0.19 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $124.6 million versus the consensus estimate of $164.8 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
... More